Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

246 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Recruiting

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

NCT05430971

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Seattle Children's Cancer and Blood Disorders Center Seattle, Washington, United States
  • Hematology Center named after prof. R. Yeolyan Yerevan, Armenia
View all 22 locations
View Trial Details
Recruiting

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

NCT04116502

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Belfast City Hospital Belfast, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
View all 47 locations
View Trial Details
Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • University of Michigan ( Site 6000) Ann Arbor, Michigan, United States
  • DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States
  • UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States
View all 21 locations
View Trial Details
Recruiting

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

NCT06093672

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emad Ibrahim, MD, Inc Redlands, California, United States
  • US Oncology Inc Englewood, Colorado, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
View all 90 locations
View Trial Details
Recruiting

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

NCT05198960

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +24 more
Locations
  • CHU d'Angers Angers, France
  • CH d'Annecy Annecy, France
  • CH d'Argenteuil Argenteuil, France
  • CH d'Avignon Avignon, France
View all 42 locations
View Trial Details

Related conditions